Advertisement

Risk management in gynaecology

  • Cathrine Holland
    Affiliations
    Cathrine Holland PhD FRCOG, Consultant Gynaecological Oncologist and Divisional Clinical Governance Lead for Gynaecology, Department of Gynaecology, Manchester University Hospitals NHS Foundation Trust, Manchester, UK. Conflicts of interest: none declared
    Search for articles by this author
Published:November 18, 2022DOI:https://doi.org/10.1016/j.ogrm.2022.10.004

      Abstract

      Healthcare providers are obliged to reduce the risk of harm to patients using their services. Robust risk management embraces a blame-free reporting culture and learning from clinical errors whilst adopting a proactive approach to the measurement of patient safety indicators. A good safety culture within an organisation provides assurance to service users, staff, and the public, that there is commitment to provision of high quality safe and effective care. Risk management is everybody's responsibility. Therefore, all clinicians must possess an understanding of risk management processes. This review outlines the key elements of risk management within gynaecology and explains how risks are identified, assessed, quantified and managed. Examples from within the gynaecological setting and the challenges and the emergent risks posed by the COVID19 pandemic, are also discussed.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Obstetrics, Gynaecology and Reproductive Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      Further reading

        • COVIDSurg Collaborative
        Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study.
        Lancet Oncol. 2021 Nov; 22: 1507-1517
        • COVIDSurg Collaborative
        Mortality and pulmonary complications in patients undergoing surgery with perioperative SARS-CoV-2 infection: an international cohort study.
        Lancet. 2020 Jul 4; 396: 27-38
        • Dindo D.
        • Demartines N.
        • Clavien P.A.
        Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey.
        Ann Surg. 2004; 240: 205-213
        • Kapur N.
        • Parand A.
        • Soukup T.
        • Reader T.
        • Sevdalis N.
        Aviation and healthcare: a comparative review with implications for patient safety.
        JSRM Open. 2016; 7: 1-10
        • Scally G.
        • Donaldson L.J.
        Clinical governance and the drive for quality improvement in the new NHS in England.
        BMJ. 1998; 317: 61-65